Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


International Journal of Experimental, Clinical, Behavioural and Technological Gerontology

Guidelines for Authors

Conflict of Interest
Ethical Requirements
Plagiarism Policy
Color Illustrations
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Page Charges
E-pub First


'Gerontology' publishes manuscripts on all aspects of experimental, clinical, behavioural, regenerative and technological science research into the aging process. It accepts particularly high-quality, original papers in all disciplines of gerontological research.

The Experimental Section contains contributions from basic gerontological research. Papers submitted for the Clinical Section discuss aetiology, pathogenesis, prevention and treatment of diseases in old age from a gerontological rather than a geriatric viewpoint. Papers dealing with behavioural development and related topics are published in the Behavioural Science Section. An extra section covers research exploring basic aspects of regeneration in biological systems and regenerative medical approaches and deals with technological devices for the elderly.

Manuscripts may be submitted in the following categories:
  • Mini-Review (invited)
  • Systematic Review (invited)
  • Original Paper
  • Study Protocol
  • Viewpoint (invited)
  • Debate (invited)
  • Short Communication
  • Letter to the Editor
Authors should indicate the category they wish their article to be considered for. The Editor-in-Chief reserves the right to arrange the submitted manuscripts into one of the four sections.


Only original papers written in English are considered and should be submitted online

Online Manuscript Submission

Should you experience any problems with your submission, please contact the Editorial Office:

Georg Wick, MD
Division for Experimental Pathology and Immunology
Innsbruck Medical University
Schöpfstrasse 45
A-6020 Innsbruck

A statement signed by all authors saying that they agree with the publication of the paper should accompany the manuscript.

Original Papers (max. 6,000 words and 40 references) must describe new research results, not published or under consideration in another journal. All papers should be arranged with an Introduction, Methods, Results and Discussion. Abbreviations should be explained and limited to a minimum. All terms abbreviated in the text, abstract and in the figures must, on the first occasion, be given in full, followed by the abbreviation (e.g. electrocardiogram (ECG)). Any papers dealing, partly or wholly, with basic science should include a few lines of description to any concept which may not be well known to some readers who are primarily practising clinicians.

Study Protocols (max. 4,000 words and 40 references) must definitely be focused on gerontological research and can only be submitted after prior approval by the Editor-in-Chief. Registration in a public trials registry is mandatory. The Clinical Trial Registration Number must be included at the end of the abstract.

Mini-Reviews (max. 4,000 words plus approx. 40 references) and occasionally Systematic Reviews are to be submitted exclusively upon solicitation by the Section Editors or by the Editors of special issues, via the Editor-in-Chief. They are not subject to page charges.

The Debate and Viewpoint categories publish arguments, critical statements and theoretical papers reflecting the authors' personal views on mechanisms of the aging process in all areas within the scope of 'Gerontology'. Manuscripts are to be submitted exclusively upon solicitation by the Section Editors, via the Editor-in-Chief, and be limited to 4,000 words and 40 references.

The Short Communications (max. 2,000 words plus approx. 10 references) must contain data derived from front-edge research and be of potential interest to a large fraction of the readership.

Letters to the Editor (max. 1,000 words plus approx. 10 references) are encouraged if they directly concern articles previously published in this journal and clinical subjects related to the matters discussed. In exceptional cases, they may also adress data published in another journal. The editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. Letters on general scientific or medical subjects in gerontology are also welcome.


Only manuscripts that conform with the Guidelines for Authors will be considered.
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication or have not already been published. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Gerontology' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

Conflict of Interest

All forms of funding and support, including that from companies, and any potential competing financial interests should be acknowledged in the cover letter to the editor. The statement has to be listed at the end of the article.

Ethical Requirements

Appropriate proof has to be provided that all ethical prerequisites have been fulfilled. These include permission granted by responsible Ethical Committees and informed consent of participants in studies on human subjects, as well as permission obtained from Review Boards for animal experiments.

Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).


Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper (no abbreviations).

All articles require an abstract, which should be structured as follows:
   Background: What prompted the study?
   Objective: What is the purpose of the study?
   Methods: How was the study carried out?
   Results: What are the most important findings?
   Conclusion: What is the most important conclusion?

Abstracts for Mini-Reviews and Viewpoints do not have to be structured.
Abstracts should not exceed 350 words. Any abbreviations must be explained.

Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figure legends should be supplied on a separate page. For technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 180×223 mm) or provide crop marks. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1200 dpi. Figure files must not be embedded in a document file but submitted separately.

Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00.


Identify references in the text with Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).


(a) Papers published in periodicals: Vilhelmsson M, Johansson C, Jacobsson-Ekman G, Crameri R, Zargari A, Scheynius A: The malassezia sympodialis allergen Mala s 11 induces human dendritic cell maturation, in contrast to its human homologue manganese superoxide dismutase. Int Arch Allergy Immunol 2007;143:155–162.

(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007.

(d) Edited books: Park BK, Sanderson JP, Naisbitt DJ: Drugs as haptens, antigens, and immunogens; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 55–65.

Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.

Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org

Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.

Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.

Page Charges

There are no page charges for papers of up to 4 printed pages (i.e. 12 typewritten pages at 33 lines per page, 65 strokes per line, including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00.


Proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.

E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.


Order form and price list are sent with the PDF proofs. Orders submitted after the issue is printed are subject to considerably higher prices.